反应详情

1-[1-(tert-butoxycarbonyl)piperidin-4-yl]-1H-pyrazole-4-carboxylic acid (134 mg, 0.45 mmol) and oxalyl chloride (0.6 mmol) were stirred in DCM dry (5 mL) at room temperature overnight. Volatiles were evaporated and the residue dissolved in dry pyridine (5 mL) at 0° C. A solution of 5-(3,5-difluoro-benzyl)-1H-indazol-3-ylamine (100 mg, 0.38 mmol) in dry pyridine (2 mL) was added to the cooled reaction mixture. After 1 hour, reaction was quenched with NaHCO3 sat. sol and extracted with ethyl acetate. Collected organic phases were dried over Na2SO4, filtered and evaporated to dryness. Residue was purified by column chromatography over silica gel (DCM/EtOH/NH3 5N in MeOH=1000/50/1) affording 87 mg of Boc-protected derivative which was dissolved in 2 mL of dioxane and trated with 0.4 mL of 4M HCl in dioxane. Volatiles were evaporated affording 65 mg of the title compound.

1. customdry (5 mL) at room temperature overnight
2. customVolatiles were evaporated
3. dissolutionthe residue dissolved in dry pyridine (5 mL) at 0° C
4. customreaction
5. customwas quenched with NaHCO3 sat. sol
6. extractionextracted with ethyl acetate
7. dry with materialCollected organic phases were dried over Na2SO4
8. filtrationfiltered
9. customevaporated to dryness
10. customResidue was purified by column chromatography over silica gel (DCM/EtOH/NH3 5N in MeOH=1000/50/1)
11. customaffording 87 mg of Boc-protected derivative which
12. customVolatiles were evaporated